TRACON Pharmaceuticals, Inc.
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the t…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
TRACON Pharmaceuticals, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
TRACON Pharmaceuticals, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of TRACON Pharmaceuticals, Inc..